Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 2/20 | 0.45 |
| ▸ | BRD4 | O60885 | 2/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.34 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.34 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.34 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.33 |
| ▸ | GLRB | P48167 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.32 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.32 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | CFTR | P13569 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL722557 | 0.82 | LTA4H (0.64) | HPGDSLTA4HBRD4CHRNA7CHRNA10 | |
| SCHEMBL5820538 | 0.80 | NOTUM (0.43) | HPGDS | |
| SCHEMBL28257875 | 0.80 | LTA4H (0.62) | HPGDSLTA4HBRD4CHRNA7CHRNA10 | |
| SCHEMBL28362996 | 0.80 | LTA4H (0.62) | HPGDSLTA4HBRD4CHRNA7CHRNA10 | |
| SCHEMBL28320605 | 0.80 | LTA4H (0.62) | HPGDSLTA4HBRD4CHRNA7CHRNA10 | |
| SCHEMBL66901 | 0.80 | HPGDS (0.48) | HPGDSLTA4HBRD4CHRNA7CHRNA10 | |
| SCHEMBL5200683 | 0.78 | HPGDS (0.35) | HPGDSLTA4HBRD4 | |
| SCHEMBL6830738 | 0.78 | CYP1A2 (0.40) | HPGDSLTA4HBRD4CHRNA7CHRNA10 | |
| SCHEMBL9455041 | 0.78 | HPGDS (0.35) | HPGDSLTA4HBRD4 | |
| SCHEMBL1919495 | 0.78 | HPGDS (0.52) | HPGDSLTA4HBRD4PIN1HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115583958-A | Synthesis method of dihydrothia (oxa) zole [3',2':1,5] dihydroimidazole [4,5-b ] piperidine derivative | 河南师范大学 | 2023-01-10 | — | — | CN | claimed |
| CN-115304606-A | Degradation agent for simultaneously targeting BTK and GSPT1 proteins | 清华大学 | 2022-11-08 | — | — | CN | claimed |
| US-20090181998-A1 | OPIOID RECEPTOR SUBTYPE-SELECTIVE AGENTS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2009-07-16 | — | — | US | claimed |
| CN-101309922-A | Amino-aza-adamantane derivatives and methods of use | ABBOTT LAB (US) | 2008-11-19 | — | — | CN | claimed |
| WO-2008064317-A1 | LIPOPHILIC OPIOID RECEPTOR ACTIVE COMPOUNDS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2008-05-29 | — | — | WO | claimed |
| WO-2008064318-A2 | PERIPHERAL OPIOID RECEPTOR ACTIVE COMPOUNDS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2008-05-29 | — | — | WO | claimed |
| EP-1819721-A1 | MICROCIN B17 ANALOGS AND METHODS FOR THEIR PREPARATION AND USE | Plant Bioscience Limited (GB) | 2007-08-22 | — | — | EP | claimed |
| WO-2006124687-A1 | OPIOID RECEPTOR SUBTYPE-SELECTIVE AGENTS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2006-11-23 | — | — | WO | claimed |
| WO-2006054102-A1 | MICROCIN B17 ANALOGS AND METHODS FOR THEIR PREPARATION AND USE | PLANT BIOSCIENCE LIMITED (GB) | 2006-05-26 | — | — | WO | claimed |
| EP-4665862-A1 | PYRUVATE SENSOR AND RELATED METHOD | Abbott Diabetes Care Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-4648680-A2 | BIOSENSORS WITH HYDROPHILIC POLYURETHANE MEMBRANES | Abbott Diabetes Care Inc. (US) | 2025-11-19 | — | — | EP | disclosed |
| US-20250281084-A1 | COMPOSITION, COATING, AND METHOD FOR REDUCING EARLY/LATE SENSOR ATTENUATION OF ANALYTE BIOSENSOR | ABBOTT DIABETES CARE INC. | 2025-09-11 | — | — | US | disclosed |
| US-20250213152-A1 | BACKGROUND INTERFERENCE MITIGATION FOR HIGH SENSITIVITY KETONE SENSING | ABBOTT DIABETES CARE INC. (US) | 2025-07-03 | — | — | US | disclosed |
| WO-2025137203-A1 | GLUCOSE OXIDASE SENSORS WITH IMPROVED STABILITY | ABBOTT DIABETES CARE, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-1995030703-A1 | ENERGY POLYMERIZABLE COMPOSITIONS, HOMOPOLYMERS AND COPOLYMERS OF OXAZOLINES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-11-16 | — | — | WO | disclosed |
| EP-0629624-A1 | Tetrazole derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-12-21 | — | — | EP | disclosed |
| EP-0627406-A1 | 2-AMINO-1,3-PROPANEDIOL COMPOUND AND IMMUNOSUPPRESSANT | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1994-12-07 | — | — | EP | disclosed |
| EP-0605228-A1 | Thiazolidinedione derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1994-07-06 | — | — | EP | disclosed |
| EP-0331554-A1 | Composition, which permits to make compatible at least two incompatible thermoplastic polymers, its application for the fabrication of thermoplastic alloys and thermoplastic alloys obtained | ELF ATOCHEM S.A. (FR) | 1989-09-06 | — | — | EP | disclosed |
| US-4254049-A | ANTIINFLAMMATORY AGENTS; USED TO INHIBIT JOINT DETERIORIATION OF ARTHRITIS | AMERICAN CYANAMID COMPANY (US) | 1981-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181998-A1 | OPIOID RECEPTOR SUBTYPE-SELECTIVE AGENTS | OPRM1, OPRK1, OPRL1 | HPGDS 565/4885LTA4H 657/4885BRD4 3730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.